ImmuCell Corporation (ICCC)
NASDAQ: ICCC Ā· Real-Time Price Ā· USD
11.17
-0.08 (-0.71%)
At close: Nov 19, 2026, 4:00 PM EST
11.19
+0.02 (0.18%)
After-hours: Nov 19, 2026, 7:30 PM EST
ImmuCell Employees
ImmuCell had 73 employees as of December 31, 2025. The number of employees decreased by 2 or 2.67% compared to the previous year. That makes ImmuCell the 33,275th largest employer in the world and 4,342nd in the United States.
Employees
73
Change (1Y)
-2
Growth (1Y)
-2.67%
Revenue / Employee
$454,923
Profits / Employee
$25,748
Market Cap
101.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Voyager Therapeutics | 141 |
| Molecular Partners AG | 134 |
| Innate Pharma | 120 |
| Cibus | 118 |
| Immunic | 100 |
| LENZ Therapeutics | 40 |
| NovaBridge Biosciences | 30 |
| Genelux | 26 |
ICCC News
- 6 days ago - ImmuCell Earnings Call Transcript: Q3 2026 - Transcripts
- 6 days ago - ImmuCell Quarterly report: Q3 2026 - Filings
- 6 days ago - ImmuCell Earnings release: Q3 2026 - Filings
- 7 days ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026 - GlobeNewsWire
- 7 days ago - ImmuCell Slides: Investor presentation - Filings
- 13 days ago - ImmuCell to Announce Unaudited Financial Results forĀ the Quarter Ended September 30, 2026 - GlobeNewsWire
- 5 weeks ago - Immucell reports preliminary Q3 revenue $8M - TheFly
- 5 weeks ago - ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results - GlobeNewsWire